Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Insmed Inc (NASDAQ:INSM)

15.81
Delayed Data
As of Mar 24
 +0.16 / +1.02%
Today’s Change
9.02
Today|||52-Week Range
17.32
+19.50%
Year-to-Date

Today’s Trading

Previous close15.65
Today’s open15.71
Day’s range15.52 - 15.90
Volume309,054
Average volume (3 months)321,369
Market cap$980.6M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-41.09%
Earnings growth (this year)+19.75%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.35

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...+0.10+2.24%
FOLDAmicus Therapeutics ...+0.10+1.40%
DEPODepomed Inc+0.05+0.34%
ALDRAlder Biopharmaceuti...+0.65+3.14%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$0.00
Annual profit (last year)-$176.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Will Lewis
Chief Financial Officer
Andrew T. Drechsler
Corporate headquarters
Bridgewater, New Jersey

Forecasts


Search for Jobs